This site is intended for healthcare professionals
News

EU awards CE mark approval to EBX 041 SARS CoV2 diagnostic test for Coronavirus.- Eurobio Scientific

Read time: 1 mins
Published:26th Mar 2020
Eurobio Scientific announced CE mark approval for its EBX 041 SARS CoV2 proprietary test, developed specifically for the clinical diagnosis of COVID-19. The EBX 041 SARS CoV2 proprietary kit follows the design recommended by the French National Reference Center (CNR) and has been approved based on clinical samples with an independent hospital. This is a multiplex kit with three targets: two for identifying the virus and one target for a control integrated into each patient test.Comment: This is a multiplexed real-time PCR test that can be used directly on a large number of open thermal cycler instruments, present in diagnostic laboratories. After extraction, it makes it possible to rapidly detect (1h15) the genes identifying the SARS COv2 virus, as recommended by the World Health Organization (WHO).
Condition: Coronavirus/COVID-19 Infection
Type: drug

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.